Sanofi Pasteur is recalling certain lots of 2009
H1N1influenza single-dose, pre-filled syringe pediatric (.25 ml)
vaccine.
Providers who have received H1N1 vaccine from the lots in
question directly from McKesson will receive a packet
with instructions from Sanofi Pasteur. Sanofi Pasteur will ship
their packets on Wednesday, December 16, 2009 for arrival on
Thursday, December 17, 2009. If these providers do not received
a packet on Thursday, December 17, 2009, they can call Capitol*
at 888-241-9288.
CDC will individually distribute to each grantee, a list
of their providers who directly received H1N1 vaccine from these
lots from McKesson later this afternoon (Tuesday, December 14,
2009).
Grantees that have redistributed H1N1 vaccine and believe that
providers who received vaccine through their redistribution
process may still have unused doses from the affected lots may
want to refer these providers to call Capitol* at 888-241-9288
to request a packet.
*Please
use this telephone number to only request recall packets.
Second Non-Safety Related Voluntary Vaccine Recall
December 23, 2009
MedImmune is recalling certain lots of 2009 H1N1
influenza monovalent nasal spray vaccine. The potency has decreased
below a pre-specified limit or was at risk of falling below that
limit in the next week. This slight decrease in potency is not
expected to have an impact on the protective response to
vaccination. For this reason, there is no need to revaccinate
persons who have received vaccine from these lots. Most of the doses
are believed to have already been administered while fully potent
and within specifications as they were shipped out in October and
early November.
Providers who have received H1N1 vaccine from
the lots in question directly from McKesson will be sent a
notification from MedImmune and instructions for returning the
vaccines will be sent as well.
County HCA redistributed some of this H1N1
vaccine to providers and these providers are being contacted by
HCA and will be given instructions on returning the vaccine.
Further information from MedImmune is available at
